Albumin replacement in patients with severe sepsis or septic shock

Andrea Cortegiani, Santi Maurizio Raineri, Antonino Giarratano, Serge Masson, Gilberto Fiore, Giacomo Grasselli, Roberto Fumagalli, Vieri Parrini, Luisa Caspani, Pietro Caironi, Stefano Faenza, Roberto Latini, Gaetano Iapichino, Luciano Gattinoni, Antonio Pesenti, Massimo Antonelli, Gianni Tognoni, Marilena Romero, Caterina Fanizza

Risultato della ricerca: Articlepeer review

550 Citazioni (Scopus)

Abstract

BACKGROUND: Although previous studies have suggested the potential advantages of albumin administration in patients with severe sepsis, its efficacy has not been fully established.METHODS:In this multicenter, open-label trial, we randomly assigned 1818 patients with severe sepsis, in 100 intensive care units (ICUs), to receive either 20% albumin and crystalloid solution or crystalloid solution alone. In the albumin group, the target serum albumin concentration was 30 g per liter or more until discharge from the ICU or 28 days after randomization. The primary outcome was death from any cause at 28 days. Secondary outcomes were death from any cause at 90 days, the number of patients with organ dysfunction and the degree of dysfunction, and length of stay in the ICU and the hospital.RESULTS:During the first 7 days, patients in the albumin group, as compared with those in the crystalloid group, had a higher mean arterial pressure (P=0.03) and lower net fluid balance (P<0.001). The total daily amount of administered fluid did not differ significantly between the two groups (P=0.10). At 28 days, 285 of 895 patients (31.8%) in the albumin group and 288 of 900 (32.0%) in the crystalloid group had died (relative risk in the albumin group, 1.00; 95% confidence interval [CI], 0.87 to 1.14; P=0.94). At 90 days, 365 of 888 patients (41.1%) in the albumin group and 389 of 893 (43.6%) in the crystalloid group had died (relative risk, 0.94; 95% CI, 0.85 to 1.05; P=0.29). No significant differences in other secondary outcomes were observed between the two groups.CONCLUSIONS:In patients with severe sepsis, albumin replacement in addition to crystalloids, as compared with crystalloids alone, did not improve the rate of survival at 28 and 90 days.
Lingua originaleEnglish
pagine (da-a)1412-1421
Numero di pagine10
RivistaNew England Journal of Medicine
Volume370
Stato di pubblicazionePublished - 2014

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2700???

Fingerprint Entra nei temi di ricerca di 'Albumin replacement in patients with severe sepsis or septic shock'. Insieme formano una fingerprint unica.

Cita questo